Kimihide Yoshida

1.4k total citations
21 papers, 1.2k citations indexed

About

Kimihide Yoshida is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Kimihide Yoshida has authored 21 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Kimihide Yoshida's work include Lung Cancer Treatments and Mutations (13 papers), Colorectal Cancer Treatments and Studies (8 papers) and Lung Cancer Research Studies (6 papers). Kimihide Yoshida is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Colorectal Cancer Treatments and Studies (8 papers) and Lung Cancer Research Studies (6 papers). Kimihide Yoshida collaborates with scholars based in Japan, United States and Myanmar. Kimihide Yoshida's co-authors include Toyoaki Hida, Tetsuya Mitsudomi, Yasushi Yatabe, Takayuki Kosaka, Masahiro Tsuboi, Hiroyuki Kuwano, Hideki Endoh, Hirohito Tada, Yoshitsugu Horio and Junichi Shimizu and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Kimihide Yoshida

21 papers receiving 1.1k citations

Peers

Kimihide Yoshida
Masato Terashima Japan
Jih‐Hsiang Lee Taiwan
Akihiko Miyanaga Japan
Chiara Biagioni Italy
Yongfeng Yu China
Xiaoran Han China
Masaoki Ito Japan
Masaya Nishino Japan
Addie Dvir Israel
Masato Terashima Japan
Kimihide Yoshida
Citations per year, relative to Kimihide Yoshida Kimihide Yoshida (= 1×) peers Masato Terashima

Countries citing papers authored by Kimihide Yoshida

Since Specialization
Citations

This map shows the geographic impact of Kimihide Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimihide Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimihide Yoshida more than expected).

Fields of papers citing papers by Kimihide Yoshida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimihide Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimihide Yoshida. The network helps show where Kimihide Yoshida may publish in the future.

Co-authorship network of co-authors of Kimihide Yoshida

This figure shows the co-authorship network connecting the top 25 collaborators of Kimihide Yoshida. A scholar is included among the top collaborators of Kimihide Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimihide Yoshida. Kimihide Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jangchul, Park, Chiaki Kondo, Junichi Shimizu, et al.. (2014). EGFR Exon 19 Insertions Show Good Response to Gefitinib, but Short Time to Progression in Japanese Patients. Journal of Thoracic Oncology. 9(2). e10–e11. 6 indexed citations
2.
Jangchul, Park, Kimihide Yoshida, Chiaki Kondo, et al.. (2013). Crizotinib-induced esophageal ulceration: A novel adverse event of crizotinib. Lung Cancer. 81(3). 495–496. 16 indexed citations
3.
Jangchul, Park, Hidekazu Yamaura, Yasushi Yatabe, et al.. (2013). Anaplastic lymphoma kinase gene rearrangements in patients with advanced‐stage non‐small‐cell lung cancer: CT characteristics and response to chemotherapy. Cancer Medicine. 3(1). 118–123. 17 indexed citations
4.
Ozeki, Naoki, Takayuki Fukui, Yukiko Niwa, et al.. (2012). Lung Adenocarcinoma Coexistent with Pulmonary Non-tuberculous Mycobacteriosis. Haigan. 52(2). 238–241. 2 indexed citations
5.
Yoshida, Kimihide, Yasushi Yatabe, Park Jangchul, et al.. (2009). Clinical outcomes of advanced non-small cell lung cancer patients screened for epidermal growth factor receptor gene mutations. Journal of Cancer Research and Clinical Oncology. 136(4). 527–535. 11 indexed citations
6.
Witta, Samir E., Kimihide Yoshida, Barbara Frederick, et al.. (2009). Synergistic effect of SNDX-275 with lapatinib or erlotinib in breast, lung, or head and neck cancer cell lines expressing HER- 2. Journal of Clinical Oncology. 27(15_suppl). e14566–e14566. 1 indexed citations
7.
Morita, Satoshi, Isamu Okamoto, Kunihiko Kobayashi, et al.. (2009). Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non–Small Cell Lung Cancer with EGFR Mutations. Clinical Cancer Research. 15(13). 4493–4498. 156 indexed citations
8.
Hida, Toyoaki, et al.. (2008). Gefitinib for the treatment of non-small-cell lung cancer. Expert Review of Anticancer Therapy. 9(1). 17–35. 49 indexed citations
9.
10.
Yoshida, Kimihide, Takahiko Sugiura, Nobuhide Takifuji, et al.. (2007). Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515. Lung Cancer. 58(3). 362–368. 48 indexed citations
11.
Yoshida, Kimihide, Yasushi Yatabe, Ji Young Park, et al.. (2007). Prospective Validation for Prediction of Gefitinib Sensitivity by Epidermal Growth Factor Receptor Gene Mutation in Patients with Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 2(1). 22–28. 143 indexed citations
12.
Yoshida, Kimihide, Yasushi Yatabe, Ji Young Park, et al.. (2007). Prospective Validation for Prediction of Gefitinib Sensitivity by Epidermal Growth Factor Receptor Gene Mutation in Patients with Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 2(1). 22–28. 98 indexed citations
13.
Kosaka, Takayuki, Yasushi Yatabe, Hideki Endoh, et al.. (2006). Analysis of Epidermal Growth Factor Receptor Gene Mutation in Patients with Non–Small Cell Lung Cancer and Acquired Resistance to Gefitinib. Clinical Cancer Research. 12(19). 5764–5769. 480 indexed citations
14.
Goto, Kōichi, Ikuo Sekine, Yutaka Nishiwaki, et al.. (2004). Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancer. British Journal of Cancer. 91(4). 659–665. 22 indexed citations
15.
Yoshida, Kimihide. (2002). [Management and types of side effects in chemotherapy for lung cancer].. PubMed. 60 Suppl 5. 384–7. 1 indexed citations
16.
Hamajima, Nobuyuki, Hidemi Ito, Keitaro Matsuo, et al.. (2002). Association between Smoking Habits and Dopamine Receptor D2 Taql A A2 Allele in Japanese Males: A Confirmatory Study.. Journal of Epidemiology. 12(4). 297–304. 33 indexed citations
17.
Yoshida, Kimihide, Nobuyuki Hamajima, Ken‐ichi Kozaki, et al.. (2001). Association between the dopamine D2 receptor A2/A2 genotype and smoking behavior in the Japanese.. PubMed. 10(4). 403–5. 44 indexed citations
18.
Yoshida, Kimihide, et al.. (1998). Expression of sucrase and intestinal-type alkaline phosphatase in colorectal carcinoms in rats treated with methylazoxymethanol acetate. Journal of Cancer Research and Clinical Oncology. 124(12). 677–682. 9 indexed citations
19.
Yoshida, Kimihide, et al.. (1994). Increase of labeling indices in gastrointestinal mucosae of mice and rats by compounds of the okadaic acid type. Journal of Cancer Research and Clinical Oncology. 120(4). 208–212. 15 indexed citations
20.
Usui, Noriaki, Kimihide Yoshida, Masashi Suzuki, et al.. (1990). [Cumulative survival rate of chemotherapy with CDDP for malignant ovarian tumors].. PubMed. 42(4). 333–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masato Terashima Breakdown of academic impact, for papers by Jih‐Hsiang Lee Breakdown of academic impact, for papers by Akihiko Miyanaga Breakdown of academic impact, for papers by Chiara Biagioni Breakdown of academic impact, for papers by Yongfeng Yu Breakdown of academic impact, for papers by Xiaoran Han Breakdown of academic impact, for papers by Masaoki Ito Breakdown of academic impact, for papers by Masaya Nishino Breakdown of academic impact, for papers by Addie Dvir
Rankless by CCL
2026